PCBN yields 1000000.00% · ABBV yields 3.06%● Live data
📍 PCBN pulled ahead of the other in Year 1
Combined, PCBN + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PCBN + ABBV for your $10,000?
Piedmont Community Bank Group, Inc. operates as the bank holding company for Piedmont Community Bank, which offers various commercial banking services to residents and small businesses in Georgia. The company offers various deposit products, including checking, money market, savings, individual retirement, time deposit accounts, demand deposits, and certificates of deposit. The company loan portfolio includes commercial real estate loans; real estate mortgage loans; construction and development loans; commercial and industrial loans; and consumer loans, such as home equity loans, automobile financing, RV financing, boat financing, loans secured by deposits, overdraft protection lines, and secured and unsecured personal loans. The company also issues ATM and debit cards, travelers' checks, and official checks; conducts wire transfer services and Internet banking; and provides safe deposit and telephone banking services, as well as offers MasterCard and VISA credit card services. It primarily serves customers located in the middle part of Georgia, including Baldwin, Bibb, Greene, Houston, Jones, Monroe, and Putnam counties. The company was formerly known as Piedmont Community Bank and changed its name to Piedmont Community Bank Group, Inc. in March 2007. The company was founded in 2002 and is based in Gray, Georgia.
Full PCBN Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.